Global Dermatology OTC Drug Market Research Report 2023
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
According to QYResearch’s new survey, global Dermatology OTC Drug market is projected to reach US$ 16340 million in 2029, increasing from US$ 12780 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dermatology OTC Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dermatology OTC Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Dermatology OTC Drug market is projected to reach US$ 16340 million in 2029, increasing from US$ 12780 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dermatology OTC Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dermatology OTC Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Bayer
- GSK
- Teva
- Johnson & Johnson
- Novartis
- Viatris
- Sun Pharmaceutical
- Aurobindo
- Galderma
- CR SANJIU
- Dr. Reddy's
- Lupin
- Bausch Health
- Cipla
- Livzon
- Almirall
- Lingrui
- Antifungals Medication
- Skin Disinfection Medication
- Skin Irritation Medication
- Wounds and Herpes Simplex Medication
- Anti-Psoriasis Medication
- Other
- Hospital
- Drug Store
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology OTC Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antifungals Medication
1.2.3 Skin Disinfection Medication
1.2.4 Skin Irritation Medication
1.2.5 Wounds and Herpes Simplex Medication
1.2.6 Anti-Psoriasis Medication
1.2.7 Other
1.3 Market by Application
1.3.1 Global Dermatology OTC Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Dermatology OTC Drug Market Perspective (2018-2029)
2.2 Dermatology OTC Drug Growth Trends by Region
2.2.1 Global Dermatology OTC Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dermatology OTC Drug Historic Market Size by Region (2018-2023)
2.2.3 Dermatology OTC Drug Forecasted Market Size by Region (2024-2029)
2.3 Dermatology OTC Drug Market Dynamics
2.3.1 Dermatology OTC Drug Industry Trends
2.3.2 Dermatology OTC Drug Market Drivers
2.3.3 Dermatology OTC Drug Market Challenges
2.3.4 Dermatology OTC Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Dermatology OTC Drug Players by Revenue
3.1.1 Global Top Dermatology OTC Drug Players by Revenue (2018-2023)
3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2018-2023)
3.2 Global Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatology OTC Drug Revenue
3.4 Global Dermatology OTC Drug Market Concentration Ratio
3.4.1 Global Dermatology OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology OTC Drug Revenue in 2022
3.5 Dermatology OTC Drug Key Players Head office and Area Served
3.6 Key Players Dermatology OTC Drug Product Solution and Service
3.7 Date of Enter into Dermatology OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DERMATOLOGY OTC DRUG BREAKDOWN DATA BY TYPE
4.1 Global Dermatology OTC Drug Historic Market Size by Type (2018-2023)
4.2 Global Dermatology OTC Drug Forecasted Market Size by Type (2024-2029)
5 DERMATOLOGY OTC DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Dermatology OTC Drug Historic Market Size by Application (2018-2023)
5.2 Global Dermatology OTC Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dermatology OTC Drug Market Size (2018-2029)
6.2 North America Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dermatology OTC Drug Market Size by Country (2018-2023)
6.4 North America Dermatology OTC Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Dermatology OTC Drug Market Size (2018-2029)
7.2 Europe Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dermatology OTC Drug Market Size by Country (2018-2023)
7.4 Europe Dermatology OTC Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Dermatology OTC Drug Market Size (2018-2029)
8.2 Asia-Pacific Dermatology OTC Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dermatology OTC Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Dermatology OTC Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Dermatology OTC Drug Market Size (2018-2029)
9.2 Latin America Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dermatology OTC Drug Market Size by Country (2018-2023)
9.4 Latin America Dermatology OTC Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dermatology OTC Drug Market Size (2018-2029)
10.2 Middle East & Africa Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dermatology OTC Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Dermatology OTC Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Dermatology OTC Drug Introduction
11.1.4 Bayer Revenue in Dermatology OTC Drug Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Dermatology OTC Drug Introduction
11.2.4 GSK Revenue in Dermatology OTC Drug Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Dermatology OTC Drug Introduction
11.3.4 Teva Revenue in Dermatology OTC Drug Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Dermatology OTC Drug Introduction
11.4.4 Johnson & Johnson Revenue in Dermatology OTC Drug Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Dermatology OTC Drug Introduction
11.5.4 Novartis Revenue in Dermatology OTC Drug Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Viatris
11.6.1 Viatris Company Detail
11.6.2 Viatris Business Overview
11.6.3 Viatris Dermatology OTC Drug Introduction
11.6.4 Viatris Revenue in Dermatology OTC Drug Business (2018-2023)
11.6.5 Viatris Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Detail
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Dermatology OTC Drug Introduction
11.7.4 Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2018-2023)
11.7.5 Sun Pharmaceutical Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Detail
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Dermatology OTC Drug Introduction
11.8.4 Aurobindo Revenue in Dermatology OTC Drug Business (2018-2023)
11.8.5 Aurobindo Recent Development
11.9 Galderma
11.9.1 Galderma Company Detail
11.9.2 Galderma Business Overview
11.9.3 Galderma Dermatology OTC Drug Introduction
11.9.4 Galderma Revenue in Dermatology OTC Drug Business (2018-2023)
11.9.5 Galderma Recent Development
11.10 CR SANJIU
11.10.1 CR SANJIU Company Detail
11.10.2 CR SANJIU Business Overview
11.10.3 CR SANJIU Dermatology OTC Drug Introduction
11.10.4 CR SANJIU Revenue in Dermatology OTC Drug Business (2018-2023)
11.10.5 CR SANJIU Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Detail
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Dermatology OTC Drug Introduction
11.11.4 Dr. Reddy's Revenue in Dermatology OTC Drug Business (2018-2023)
11.11.5 Dr. Reddy's Recent Development
11.12 Lupin
11.12.1 Lupin Company Detail
11.12.2 Lupin Business Overview
11.12.3 Lupin Dermatology OTC Drug Introduction
11.12.4 Lupin Revenue in Dermatology OTC Drug Business (2018-2023)
11.12.5 Lupin Recent Development
11.13 Bausch Health
11.13.1 Bausch Health Company Detail
11.13.2 Bausch Health Business Overview
11.13.3 Bausch Health Dermatology OTC Drug Introduction
11.13.4 Bausch Health Revenue in Dermatology OTC Drug Business (2018-2023)
11.13.5 Bausch Health Recent Development
11.14 Cipla
11.14.1 Cipla Company Detail
11.14.2 Cipla Business Overview
11.14.3 Cipla Dermatology OTC Drug Introduction
11.14.4 Cipla Revenue in Dermatology OTC Drug Business (2018-2023)
11.14.5 Cipla Recent Development
11.15 Livzon
11.15.1 Livzon Company Detail
11.15.2 Livzon Business Overview
11.15.3 Livzon Dermatology OTC Drug Introduction
11.15.4 Livzon Revenue in Dermatology OTC Drug Business (2018-2023)
11.15.5 Livzon Recent Development
11.16 Almirall
11.16.1 Almirall Company Detail
11.16.2 Almirall Business Overview
11.16.3 Almirall Dermatology OTC Drug Introduction
11.16.4 Almirall Revenue in Dermatology OTC Drug Business (2018-2023)
11.16.5 Almirall Recent Development
11.17 Lingrui
11.17.1 Lingrui Company Detail
11.17.2 Lingrui Business Overview
11.17.3 Lingrui Dermatology OTC Drug Introduction
11.17.4 Lingrui Revenue in Dermatology OTC Drug Business (2018-2023)
11.17.5 Lingrui Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology OTC Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antifungals Medication
1.2.3 Skin Disinfection Medication
1.2.4 Skin Irritation Medication
1.2.5 Wounds and Herpes Simplex Medication
1.2.6 Anti-Psoriasis Medication
1.2.7 Other
1.3 Market by Application
1.3.1 Global Dermatology OTC Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Dermatology OTC Drug Market Perspective (2018-2029)
2.2 Dermatology OTC Drug Growth Trends by Region
2.2.1 Global Dermatology OTC Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dermatology OTC Drug Historic Market Size by Region (2018-2023)
2.2.3 Dermatology OTC Drug Forecasted Market Size by Region (2024-2029)
2.3 Dermatology OTC Drug Market Dynamics
2.3.1 Dermatology OTC Drug Industry Trends
2.3.2 Dermatology OTC Drug Market Drivers
2.3.3 Dermatology OTC Drug Market Challenges
2.3.4 Dermatology OTC Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Dermatology OTC Drug Players by Revenue
3.1.1 Global Top Dermatology OTC Drug Players by Revenue (2018-2023)
3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2018-2023)
3.2 Global Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatology OTC Drug Revenue
3.4 Global Dermatology OTC Drug Market Concentration Ratio
3.4.1 Global Dermatology OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology OTC Drug Revenue in 2022
3.5 Dermatology OTC Drug Key Players Head office and Area Served
3.6 Key Players Dermatology OTC Drug Product Solution and Service
3.7 Date of Enter into Dermatology OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DERMATOLOGY OTC DRUG BREAKDOWN DATA BY TYPE
4.1 Global Dermatology OTC Drug Historic Market Size by Type (2018-2023)
4.2 Global Dermatology OTC Drug Forecasted Market Size by Type (2024-2029)
5 DERMATOLOGY OTC DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Dermatology OTC Drug Historic Market Size by Application (2018-2023)
5.2 Global Dermatology OTC Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dermatology OTC Drug Market Size (2018-2029)
6.2 North America Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dermatology OTC Drug Market Size by Country (2018-2023)
6.4 North America Dermatology OTC Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Dermatology OTC Drug Market Size (2018-2029)
7.2 Europe Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dermatology OTC Drug Market Size by Country (2018-2023)
7.4 Europe Dermatology OTC Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Dermatology OTC Drug Market Size (2018-2029)
8.2 Asia-Pacific Dermatology OTC Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dermatology OTC Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Dermatology OTC Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Dermatology OTC Drug Market Size (2018-2029)
9.2 Latin America Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dermatology OTC Drug Market Size by Country (2018-2023)
9.4 Latin America Dermatology OTC Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dermatology OTC Drug Market Size (2018-2029)
10.2 Middle East & Africa Dermatology OTC Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dermatology OTC Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Dermatology OTC Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Dermatology OTC Drug Introduction
11.1.4 Bayer Revenue in Dermatology OTC Drug Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Dermatology OTC Drug Introduction
11.2.4 GSK Revenue in Dermatology OTC Drug Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Dermatology OTC Drug Introduction
11.3.4 Teva Revenue in Dermatology OTC Drug Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Dermatology OTC Drug Introduction
11.4.4 Johnson & Johnson Revenue in Dermatology OTC Drug Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Dermatology OTC Drug Introduction
11.5.4 Novartis Revenue in Dermatology OTC Drug Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Viatris
11.6.1 Viatris Company Detail
11.6.2 Viatris Business Overview
11.6.3 Viatris Dermatology OTC Drug Introduction
11.6.4 Viatris Revenue in Dermatology OTC Drug Business (2018-2023)
11.6.5 Viatris Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Detail
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Dermatology OTC Drug Introduction
11.7.4 Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2018-2023)
11.7.5 Sun Pharmaceutical Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Detail
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Dermatology OTC Drug Introduction
11.8.4 Aurobindo Revenue in Dermatology OTC Drug Business (2018-2023)
11.8.5 Aurobindo Recent Development
11.9 Galderma
11.9.1 Galderma Company Detail
11.9.2 Galderma Business Overview
11.9.3 Galderma Dermatology OTC Drug Introduction
11.9.4 Galderma Revenue in Dermatology OTC Drug Business (2018-2023)
11.9.5 Galderma Recent Development
11.10 CR SANJIU
11.10.1 CR SANJIU Company Detail
11.10.2 CR SANJIU Business Overview
11.10.3 CR SANJIU Dermatology OTC Drug Introduction
11.10.4 CR SANJIU Revenue in Dermatology OTC Drug Business (2018-2023)
11.10.5 CR SANJIU Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Detail
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Dermatology OTC Drug Introduction
11.11.4 Dr. Reddy's Revenue in Dermatology OTC Drug Business (2018-2023)
11.11.5 Dr. Reddy's Recent Development
11.12 Lupin
11.12.1 Lupin Company Detail
11.12.2 Lupin Business Overview
11.12.3 Lupin Dermatology OTC Drug Introduction
11.12.4 Lupin Revenue in Dermatology OTC Drug Business (2018-2023)
11.12.5 Lupin Recent Development
11.13 Bausch Health
11.13.1 Bausch Health Company Detail
11.13.2 Bausch Health Business Overview
11.13.3 Bausch Health Dermatology OTC Drug Introduction
11.13.4 Bausch Health Revenue in Dermatology OTC Drug Business (2018-2023)
11.13.5 Bausch Health Recent Development
11.14 Cipla
11.14.1 Cipla Company Detail
11.14.2 Cipla Business Overview
11.14.3 Cipla Dermatology OTC Drug Introduction
11.14.4 Cipla Revenue in Dermatology OTC Drug Business (2018-2023)
11.14.5 Cipla Recent Development
11.15 Livzon
11.15.1 Livzon Company Detail
11.15.2 Livzon Business Overview
11.15.3 Livzon Dermatology OTC Drug Introduction
11.15.4 Livzon Revenue in Dermatology OTC Drug Business (2018-2023)
11.15.5 Livzon Recent Development
11.16 Almirall
11.16.1 Almirall Company Detail
11.16.2 Almirall Business Overview
11.16.3 Almirall Dermatology OTC Drug Introduction
11.16.4 Almirall Revenue in Dermatology OTC Drug Business (2018-2023)
11.16.5 Almirall Recent Development
11.17 Lingrui
11.17.1 Lingrui Company Detail
11.17.2 Lingrui Business Overview
11.17.3 Lingrui Dermatology OTC Drug Introduction
11.17.4 Lingrui Revenue in Dermatology OTC Drug Business (2018-2023)
11.17.5 Lingrui Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Dermatology OTC Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antifungals Medication
Table 3. Key Players of Skin Disinfection Medication
Table 4. Key Players of Skin Irritation Medication
Table 5. Key Players of Wounds and Herpes Simplex Medication
Table 6. Key Players of Anti-Psoriasis Medication
Table 7. Key Players of Other
Table 8. Global Dermatology OTC Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Dermatology OTC Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Dermatology OTC Drug Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Dermatology OTC Drug Market Share by Region (2018-2023)
Table 12. Global Dermatology OTC Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Dermatology OTC Drug Market Share by Region (2024-2029)
Table 14. Dermatology OTC Drug Market Trends
Table 15. Dermatology OTC Drug Market Drivers
Table 16. Dermatology OTC Drug Market Challenges
Table 17. Dermatology OTC Drug Market Restraints
Table 18. Global Dermatology OTC Drug Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Dermatology OTC Drug Market Share by Players (2018-2023)
Table 20. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2022)
Table 21. Ranking of Global Top Dermatology OTC Drug Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Dermatology OTC Drug Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dermatology OTC Drug Product Solution and Service
Table 25. Date of Enter into Dermatology OTC Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Dermatology OTC Drug Revenue Market Share by Type (2018-2023)
Table 29. Global Dermatology OTC Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Dermatology OTC Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Dermatology OTC Drug Revenue Market Share by Application (2018-2023)
Table 33. Global Dermatology OTC Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Dermatology OTC Drug Revenue Market Share by Application (2024-2029)
Table 35. North America Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Dermatology OTC Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Dermatology OTC Drug Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Dermatology OTC Drug Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 50. Bayer Company Detail
Table 51. Bayer Business Overview
Table 52. Bayer Dermatology OTC Drug Product
Table 53. Bayer Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. GSK Company Detail
Table 56. GSK Business Overview
Table 57. GSK Dermatology OTC Drug Product
Table 58. GSK Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 59. GSK Recent Development
Table 60. Teva Company Detail
Table 61. Teva Business Overview
Table 62. Teva Dermatology OTC Drug Product
Table 63. Teva Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 64. Teva Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Dermatology OTC Drug Product
Table 68. Johnson & Johnson Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Novartis Company Detail
Table 71. Novartis Business Overview
Table 72. Novartis Dermatology OTC Drug Product
Table 73. Novartis Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Viatris Company Detail
Table 76. Viatris Business Overview
Table 77. Viatris Dermatology OTC Drug Product
Table 78. Viatris Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 79. Viatris Recent Development
Table 80. Sun Pharmaceutical Company Detail
Table 81. Sun Pharmaceutical Business Overview
Table 82. Sun Pharmaceutical Dermatology OTC Drug Product
Table 83. Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 84. Sun Pharmaceutical Recent Development
Table 85. Aurobindo Company Detail
Table 86. Aurobindo Business Overview
Table 87. Aurobindo Dermatology OTC Drug Product
Table 88. Aurobindo Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 89. Aurobindo Recent Development
Table 90. Galderma Company Detail
Table 91. Galderma Business Overview
Table 92. Galderma Dermatology OTC Drug Product
Table 93. Galderma Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 94. Galderma Recent Development
Table 95. CR SANJIU Company Detail
Table 96. CR SANJIU Business Overview
Table 97. CR SANJIU Dermatology OTC Drug Product
Table 98. CR SANJIU Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 99. CR SANJIU Recent Development
Table 100. Dr. Reddy's Company Detail
Table 101. Dr. Reddy's Business Overview
Table 102. Dr. Reddy's Dermatology OTC Drug Product
Table 103. Dr. Reddy's Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 104. Dr. Reddy's Recent Development
Table 105. Lupin Company Detail
Table 106. Lupin Business Overview
Table 107. Lupin Dermatology OTC Drug Product
Table 108. Lupin Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 109. Lupin Recent Development
Table 110. Bausch Health Company Detail
Table 111. Bausch Health Business Overview
Table 112. Bausch Health Dermatology OTC Drug Product
Table 113. Bausch Health Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 114. Bausch Health Recent Development
Table 115. Cipla Company Detail
Table 116. Cipla Business Overview
Table 117. Cipla Dermatology OTC Drug Product
Table 118. Cipla Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 119. Cipla Recent Development
Table 120. Livzon Company Detail
Table 121. Livzon Business Overview
Table 122. Livzon Dermatology OTC Drug Product
Table 123. Livzon Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 124. Livzon Recent Development
Table 125. Almirall Company Detail
Table 126. Almirall Business Overview
Table 127. Almirall Dermatology OTC Drug Product
Table 128. Almirall Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 129. Almirall Recent Development
Table 130. Lingrui Company Detail
Table 131. Lingrui Business Overview
Table 132. Lingrui Dermatology OTC Drug Product
Table 133. Lingrui Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 134. Lingrui Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 1. Global Dermatology OTC Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antifungals Medication
Table 3. Key Players of Skin Disinfection Medication
Table 4. Key Players of Skin Irritation Medication
Table 5. Key Players of Wounds and Herpes Simplex Medication
Table 6. Key Players of Anti-Psoriasis Medication
Table 7. Key Players of Other
Table 8. Global Dermatology OTC Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Dermatology OTC Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Dermatology OTC Drug Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Dermatology OTC Drug Market Share by Region (2018-2023)
Table 12. Global Dermatology OTC Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Dermatology OTC Drug Market Share by Region (2024-2029)
Table 14. Dermatology OTC Drug Market Trends
Table 15. Dermatology OTC Drug Market Drivers
Table 16. Dermatology OTC Drug Market Challenges
Table 17. Dermatology OTC Drug Market Restraints
Table 18. Global Dermatology OTC Drug Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Dermatology OTC Drug Market Share by Players (2018-2023)
Table 20. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2022)
Table 21. Ranking of Global Top Dermatology OTC Drug Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Dermatology OTC Drug Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dermatology OTC Drug Product Solution and Service
Table 25. Date of Enter into Dermatology OTC Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Dermatology OTC Drug Revenue Market Share by Type (2018-2023)
Table 29. Global Dermatology OTC Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Dermatology OTC Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Dermatology OTC Drug Revenue Market Share by Application (2018-2023)
Table 33. Global Dermatology OTC Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Dermatology OTC Drug Revenue Market Share by Application (2024-2029)
Table 35. North America Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Dermatology OTC Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Dermatology OTC Drug Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Dermatology OTC Drug Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Dermatology OTC Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dermatology OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 50. Bayer Company Detail
Table 51. Bayer Business Overview
Table 52. Bayer Dermatology OTC Drug Product
Table 53. Bayer Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. GSK Company Detail
Table 56. GSK Business Overview
Table 57. GSK Dermatology OTC Drug Product
Table 58. GSK Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 59. GSK Recent Development
Table 60. Teva Company Detail
Table 61. Teva Business Overview
Table 62. Teva Dermatology OTC Drug Product
Table 63. Teva Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 64. Teva Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Dermatology OTC Drug Product
Table 68. Johnson & Johnson Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Novartis Company Detail
Table 71. Novartis Business Overview
Table 72. Novartis Dermatology OTC Drug Product
Table 73. Novartis Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Viatris Company Detail
Table 76. Viatris Business Overview
Table 77. Viatris Dermatology OTC Drug Product
Table 78. Viatris Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 79. Viatris Recent Development
Table 80. Sun Pharmaceutical Company Detail
Table 81. Sun Pharmaceutical Business Overview
Table 82. Sun Pharmaceutical Dermatology OTC Drug Product
Table 83. Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 84. Sun Pharmaceutical Recent Development
Table 85. Aurobindo Company Detail
Table 86. Aurobindo Business Overview
Table 87. Aurobindo Dermatology OTC Drug Product
Table 88. Aurobindo Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 89. Aurobindo Recent Development
Table 90. Galderma Company Detail
Table 91. Galderma Business Overview
Table 92. Galderma Dermatology OTC Drug Product
Table 93. Galderma Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 94. Galderma Recent Development
Table 95. CR SANJIU Company Detail
Table 96. CR SANJIU Business Overview
Table 97. CR SANJIU Dermatology OTC Drug Product
Table 98. CR SANJIU Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 99. CR SANJIU Recent Development
Table 100. Dr. Reddy's Company Detail
Table 101. Dr. Reddy's Business Overview
Table 102. Dr. Reddy's Dermatology OTC Drug Product
Table 103. Dr. Reddy's Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 104. Dr. Reddy's Recent Development
Table 105. Lupin Company Detail
Table 106. Lupin Business Overview
Table 107. Lupin Dermatology OTC Drug Product
Table 108. Lupin Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 109. Lupin Recent Development
Table 110. Bausch Health Company Detail
Table 111. Bausch Health Business Overview
Table 112. Bausch Health Dermatology OTC Drug Product
Table 113. Bausch Health Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 114. Bausch Health Recent Development
Table 115. Cipla Company Detail
Table 116. Cipla Business Overview
Table 117. Cipla Dermatology OTC Drug Product
Table 118. Cipla Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 119. Cipla Recent Development
Table 120. Livzon Company Detail
Table 121. Livzon Business Overview
Table 122. Livzon Dermatology OTC Drug Product
Table 123. Livzon Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 124. Livzon Recent Development
Table 125. Almirall Company Detail
Table 126. Almirall Business Overview
Table 127. Almirall Dermatology OTC Drug Product
Table 128. Almirall Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 129. Almirall Recent Development
Table 130. Lingrui Company Detail
Table 131. Lingrui Business Overview
Table 132. Lingrui Dermatology OTC Drug Product
Table 133. Lingrui Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 134. Lingrui Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Dermatology OTC Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Dermatology OTC Drug Market Share by Type: 2022 VS 2029
Figure 3. Antifungals Medication Features
Figure 4. Skin Disinfection Medication Features
Figure 5. Skin Irritation Medication Features
Figure 6. Wounds and Herpes Simplex Medication Features
Figure 7. Anti-Psoriasis Medication Features
Figure 8. Other Features
Figure 9. Global Dermatology OTC Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Dermatology OTC Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Drug Store Case Studies
Figure 13. Other Case Studies
Figure 14. Dermatology OTC Drug Report Years Considered
Figure 15. Global Dermatology OTC Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Dermatology OTC Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Dermatology OTC Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Dermatology OTC Drug Market Share by Players in 2022
Figure 19. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Dermatology OTC Drug Revenue in 2022
Figure 21. North America Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 23. United States Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 27. Germany Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Dermatology OTC Drug Market Share by Region (2018-2029)
Figure 35. China Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 43. Mexico Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 47. Turkey Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Bayer Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 50. GSK Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 54. Viatris Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 55. Sun Pharmaceutical Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 56. Aurobindo Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 57. Galderma Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 58. CR SANJIU Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 59. Dr. Reddy's Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 60. Lupin Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 61. Bausch Health Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 62. Cipla Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 63. Livzon Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 64. Almirall Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 65. Lingrui Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Dermatology OTC Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Dermatology OTC Drug Market Share by Type: 2022 VS 2029
Figure 3. Antifungals Medication Features
Figure 4. Skin Disinfection Medication Features
Figure 5. Skin Irritation Medication Features
Figure 6. Wounds and Herpes Simplex Medication Features
Figure 7. Anti-Psoriasis Medication Features
Figure 8. Other Features
Figure 9. Global Dermatology OTC Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Dermatology OTC Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Drug Store Case Studies
Figure 13. Other Case Studies
Figure 14. Dermatology OTC Drug Report Years Considered
Figure 15. Global Dermatology OTC Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Dermatology OTC Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Dermatology OTC Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Dermatology OTC Drug Market Share by Players in 2022
Figure 19. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Dermatology OTC Drug Revenue in 2022
Figure 21. North America Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 23. United States Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 27. Germany Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Dermatology OTC Drug Market Share by Region (2018-2029)
Figure 35. China Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 43. Mexico Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Dermatology OTC Drug Market Share by Country (2018-2029)
Figure 47. Turkey Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Dermatology OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Bayer Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 50. GSK Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 54. Viatris Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 55. Sun Pharmaceutical Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 56. Aurobindo Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 57. Galderma Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 58. CR SANJIU Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 59. Dr. Reddy's Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 60. Lupin Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 61. Bausch Health Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 62. Cipla Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 63. Livzon Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 64. Almirall Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 65. Lingrui Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
